Pentec Health Is Making Headlines

Why are organizations such as the Team Pennsylvania Foundation, The Philadelphia 100®, Inc. 5000 and others impressed with Pentec? Scan our index below to learn more about our most recent achievements.

Press, News and Events

Pentec Health Names Matthew Deans President and Chief Executive Officer, Continuing Focus on Strategic Growth and Expansion of Patient Care Services and Products to Address Complex Care Needs

April 10, 2023

Pentec Health Inc., a nationwide leader in providing patient-specific compounded sterile medications and complex in-home clinical services, announced today that Matthew Deans would lead the company as President and Chief Executive Officer, effective April 10.

Pentec Health Names Matthew Deans President and Chief Executive Officer, Continuing Focus on Strategic Growth and Expansion of Patient Care Services and Products to Address Complex Care Needs

April 10, 2023 | Press, News and Events

Pentec Health Inc., a nationwide leader in providing patient-specific compounded sterile medications and complex in-home clinical services, announced today that Matthew Deans would lead the company as President and Chief Executive Officer, effective April 10.

Pentec Health Inc., Will Be Featured on a Special Episode of “The Balancing Act®” Airing on Lifetime®

February 23, 2023 | Press, News and Events

The episode will highlight the benefits of Proplete® Intradialytic Parenteral Nutrition (IDPN) and Intraperitoneal Nutrition (IPN) protein therapies for malnourished hemodialysis and peritoneal dialysis patients.

Transitional Care Units in Dialysis

July 18, 2022 | Press, Blog

Despite continuous efforts to educate on CKD, many patients starting dialysis in the United States still are not aware of, or understand, dialysis.

Pentec Health welcomes Eric C. Mollman as Chief Financial Officer

March 21, 2022 | Press

Pentec Health Inc., a nationwide leader in providing patient-specific compounded sterile medications and complex in-home clinical services, welcomes Eric C. Mollman, Chief Financial Officer.

Pentec Health Inc., welcomes Matthew L. Deans as Chief Strategy Officer and Executive Vice President of the Renal Division

January 27, 2022 | Press

Pentec Health Inc., a nationwide leader in providing patient-specific compounded sterile medications and complex in-home clinical services, welcomes Matthew L. Deans as Chief Strategy Officer and Executive Vice President of the Renal Division.

Pentec Health Inc. Acquired by Wellspring Capital Management

October 11, 2021 | Press

Pentec Health Inc., a nationwide leader in patient-specific sterile compounding, announces its acquisition by Wellspring Capital Management (“Wellspring”), a leading private equity firm headquartered in New York.

Pentec Health Inc., Celebrates 25 Years of Earning the Gold Seal of Approval® for Home Care Accreditation from The Joint Commission

August 26, 2021 | Press

Pentec Health Inc., has earned The Joint Commission’s Gold Seal of Approval® for Home Care Accreditation for the 25th year by demonstrating continuous compliance with its performance standards.

Pentec Health’s Intrathecal Nurse Fellowship is Accredited with Distinction as a Practice Transition Program by the American Nurses Credentialing Center’s Commission on Accreditation in Practice Transition Programs

November 6, 2019 | Press

Pentec Health, Inc. is honored to announce that accreditation as a practice transition program has been granted for three years through The American Nurses Credentialing Center’s Commission on Accreditation in Practice Transition Programs.

Pentec Health Announces Expansion of Aetna Coverage to their Coventry Medicare Plan

June 26, 2019 | Press

Pentec Health, Inc. today announced that Aetna, one of the country's leading health plans, will expand coverage for their Renal Nutrition Services and their Intrathecal (IT) pump management program under its Coventry Medicare plan, reaching 5.3 million lives across the country.